Latest NVO News - FDA approves Novo Nordisk's new Wegovy ...
Follow Novo Nordisk A/S (NVO) news, including Wegovy approvals, GLP‑1 obesity and MASH updates, pricing programs, pipeline data, and key corporate announcements.
www.stocktitan.netHere are the latest publicly reported updates on Novo Nordisk.
Company-wide news and press releases
Market and regulatory context (recent highlights)
Financial and clinical updates (selection)
Illustration of where to look first
If you’d like, I can monitor for new articles and summarize them with timestamped headlines and key takeaways. I can also pull a quick side-by-side of recent Wegovy pricing updates by region if you specify your preferred markets.
Citations:
Follow Novo Nordisk A/S (NVO) news, including Wegovy approvals, GLP‑1 obesity and MASH updates, pricing programs, pipeline data, and key corporate announcements.
www.stocktitan.netnews
www.prnewswire.comdanish drug maker novo nordisk Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. danish drug maker novo nordisk Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comWelcome to Novo Nordisk's U.S. news and media hub. Here you can access our news releases, social media accounts, media contacts, sign up for email alerts, and more.
www.novonordisk-us.comFind archived news and media from Novo Nordisk U.S.
www.novonordisk-us.comA one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers. Novo Nordisk said the job cuts will eliminate about 11% of its workforce, with 5,000 of the reductions in Denmark. The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the price of Wegovy, a medication with the same active ingredient that's approved for weight loss. Dr. Celine Gounder has more on the emerging price competition over the...
www.cbsnews.comHere journalists can access a concise and up-to-date overview of our company’s key facts, figures, and milestones.
www.novonordisk.comNovo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
www.novonordisk.com